526 related articles for article (PubMed ID: 22137796)
1. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.
Challa-Malladi M; Lieu YK; Califano O; Holmes AB; Bhagat G; Murty VV; Dominguez-Sola D; Pasqualucci L; Dalla-Favera R
Cancer Cell; 2011 Dec; 20(6):728-40. PubMed ID: 22137796
[TBL] [Abstract][Full Text] [Related]
2. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
[TBL] [Abstract][Full Text] [Related]
3. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
[TBL] [Abstract][Full Text] [Related]
4. Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.
Cao Y; Zhu T; Zhang P; Xiao M; Yi S; Yang Y; Li Q; Ling S; Wang Y; Gao L; Zhu L; Wang J; Wang N; Huang L; Zhang P; Zhai Q; Qiu L; Zhou J
Oncotarget; 2016 Dec; 7(50):83294-83307. PubMed ID: 27825110
[TBL] [Abstract][Full Text] [Related]
5. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
6. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
7. CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse.
Abdul Razak FR; Diepstra A; Visser L; van den Berg A
Genes Immun; 2016 Sep; 17(6):363-6. PubMed ID: 27467287
[TBL] [Abstract][Full Text] [Related]
8. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
Hicklin DJ; Dellaratta DV; Kishore R; Liang B; Kageshita T; Ferrone S
Melanoma Res; 1997 Aug; 7 Suppl 2():S67-74. PubMed ID: 9578419
[TBL] [Abstract][Full Text] [Related]
9. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
10. Gene inactivation promotes immune escape in DLBCL.
Cancer Discov; 2012 Feb; 2(2):OF8. PubMed ID: 22585868
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.
Jordanova ES; Philippo K; Giphart MJ; Schuuring E; Kluin PM
Immunogenetics; 2003 Jul; 55(4):203-9. PubMed ID: 12756506
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
13. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
14. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.
Veldman J; Visser L; Huberts-Kregel M; Muller N; Hepkema B; van den Berg A; Diepstra A
Blood; 2020 Nov; 136(21):2437-2441. PubMed ID: 32589698
[TBL] [Abstract][Full Text] [Related]
15. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
16. EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.
Otsuka Y; Nishikori M; Arima H; Izumi K; Kitawaki T; Hishizawa M; Takaori-Kondo A
Mol Immunol; 2020 Mar; 119():35-45. PubMed ID: 31962268
[TBL] [Abstract][Full Text] [Related]
17. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
18. CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.
Ghosh A; Marques-Piubelli ML; Wang X; Sheu TG; Cheng J; Khan K; Lu W; Manning J; Tang G; Solis LM; Vega F
Virchows Arch; 2022 Oct; 481(4):659-663. PubMed ID: 35622145
[TBL] [Abstract][Full Text] [Related]
19. Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.
Trichet V; Benezech C; Dousset C; Gesnel MC; Bonneville M; Breathnach R
J Immunol; 2006 Nov; 177(9):6129-36. PubMed ID: 17056540
[TBL] [Abstract][Full Text] [Related]
20. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
